Comparing the outcome of delayed postoperative versus intraoperative mitomycin C use in trabeculectomy: A randomized control trial

Abstract

Purpose

To compare the effect of delayed postoperative mitomycin C (MMC) application on surgical outcome and bleb morphology with intra-operative application in trabeculectomy.

Method

This monocentric, unmasked randomized control trial recruited primary glaucoma patients between 18–70 years of age. They were randomized into Group I (intraoperative MMC group) and Group II (postoperative MMC group). All patients underwent standard fornix-based trabeculectomy with differences only in the MMC application step. In Group I, 0.2 mg/ml MMC was applied intraoperatively for two minutes, while in Group II, 0.01 mg (0.25 ml of 0.04 mg/ml) of MMC was injected 7–14 days postoperatively above the bleb. The primary outcome was surgical success, whereas the secondary outcome measures were rate of complications and bleb morphology. Complete and qualified success was defined as intraocular pressure (IOP) between 6–21 mm Hg without and with ≤2 anti-glaucoma medications (AGMs).

Results

Fifty-six eyes (31 in Group I and 25 in Group II) were analyzed for the outcome at 18 months follow-up. Surgical success was comparable (70.9% vs 68%) (p = 0.811) between the groups. There were higher incidences of hypotony (41.9% vs 36%) in Group I. Incidences of persistent-hypotony (p = 0.032) and late-hypotony (p = 0.127) were higher in Group I. Two eyes developed hypotony maculopathy in Group I, while none in Group II. The blebs in Group I were more avascular, cystic and developed thinning, while those in Group II were diffuse and shallow.

Conclusions

Delayed postoperative MMC application may be as effective as standard trabeculectomy with MMC in lowering IOP with a lower rate of complications.

Keywords

Trabeculectomy antimetabolites mitomycin C hypotony choroidal effusion hypotony maculopathy bleb morphology.

Get full access to this article

View all access options for this article.

References

Watson

Jakeman

Ozturk

, et al. The complications of trabeculectomy: a 20 year follow up. Eye 1990; 4: 425–438.

Skuta

Parrish

2nd . Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987; 32: 149–170.

Yoon

Singh

. Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol 2004; 15: 141–146.

Habash

Aljasim

Owaidhah

, et al. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin Ophthalmol 2015 Oct 20; 9: 1945–1951.

Edmunds

Thompson

Salmon

, et al. The national survey of trabeculectomy. III. Early and late complications. Eye 2002; 16: 297–303.

Apostolov

Siarov

. Subconjunctival injection of low-dose mitomycin-C for treatment of failing human trabeculectomies. Int Ophthalmol 1996–1997; 20: 101–105.

Cantor

Mantravadi

WuDunn

, et al. Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana bleb appearance grading scale. J Glaucoma 2003; 12: 266–271.

Gedde

Schiffman

Feuer

, et al. Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol 2009 Nov; 148: 670–684.

Seet

Lee

, et al. Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation. Mol Med 2011; 17: 557–567.

10.

Robin

Ramakrishnan

Krishnadas

, et al. A long-term dose–response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997; 115: 969–974.

11.

Wilkins

Indar

Wormald

. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst. Rev 2001; 2005: CD002897.

12.

Kim

Sexton

Shin

, et al. Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-min versus 3- to 5-min mitomycin C. Am J Ophthalmol 1998; 126: 755–762.

13.

Laube

Ritters

Selbach

, et al. Clinical experiences and results of mitomycin C in trabeculectomy. Klin Monbl Augenheilkd 2003; 220: 618–624.

14.

Lee

Park

Youn

. The effect of low- and high-dose adjunctive mitomycin C in trabeculectomy. Korean J Ophthalmol 1996; 10: 42–47.

15.

Sihota

Angmo

Chandra

, et al. Evaluating the long-term efficacy of short-duration 0.1 mg/mL and 0.2 mg/mL MMC in primary trabeculectomy for primary adult glaucoma. Graefes Arch Clin Exp Ophthalmol 2015; 253: 1153–1159.

16.

Casson

Rahman

Salmon

. Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85: 686–688.

17.

Fan Gaskin

Nguyen

Ang

, et al. Wound healing modulation in glaucoma filtration surgery–conventional practices and new perspectives: the role of antifibrotic agents (part I). J Curr Glaucoma Pract 2014; 8: 37–45.

18.

Finnson

McLean

Di Guglielmo

, et al. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv Wound Care 2013; 2: 195–214.

19.

Zahid

Musch

Niziol

, et al. Risk of endophthalmitis and other long-term complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2013; 155: 674–680.

20.

Jampel

Pasquale

Dibernardo

. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol 1992; 110: 1049–1050.

21.

Greenfield

Liebmann

Jee

, et al. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998; 116: 443–447.

22.

Waheed

Liebmann

Greenfield

, et al. Recurrent bleb infections. Br J Ophthalmol 1998; 82: 926–929.

23.

Olayanju

Hassan

Hodge

, et al. Trabeculectomy-related complications in olmsted county, Minnesota, 1985 through 2010. JAMA Ophthalmol 2015; 133: 574–580.

24.

Costa

Wilson

Moster

, et al. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surg 1993 Jun; 24: 389–394. PMID: 8336889.

25.

Bindlish

Condon

Schlosser

, et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002 Jul 1; 109: 1336–1341.

26.

Rabiolo

Triolo

Khaliliyeh

, et al. Hypotony failure criteria in glaucoma surgical studies and their influence on surgery success. Ophthalmology 2024 July; 131: 803–814.

27.

Mietz

Jacobi

Krieglstein

. Postoperative application of mitomycin for trabeculectomies. Arch Ophthalmol 2000; 118: 1341–1348.

28.

Tsai

Chang

Kao

, et al. Trabeculectomy with mitomycin C versus trabeculectomy alone for juvenile primary open-angle glaucoma. Ophthalmologica 2003; 217: 24–30.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB